Every manufacturer bringing coronary assessment technology to market across the coronary artery assessment market must navigate both a regulatory pathway, FDA clearance, CE marking or MDR compliance, and, increasingly, a distinct compliance standard for AI/ML-enabled software and cloud data systems. These dimensions cannot meaningfully be evaluated separately, since a platform's underlying tec
View Detail